Westside Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $50.1K | Hold |
100
| – | – | 0.01% | 587 |
|
|
2026
Q1 | $49.1K | Hold |
100
| – | – | 0.01% | 573 |
|
|
2025
Q4 | $59.1K | Buy |
100
+3
| +3% | +$1.7K | 0.01% | 497 |
|
|
2025
Q3 | $51.2K | Hold |
97
| – | – | 0.01% | 533 |
|
|
2025
Q2 | $40.8K | Buy |
97
+61
| +169% | +$25.5K | 0.01% | 491 |
|
|
2025
Q1 | $17.6K | Hold |
36
| – | – | ﹤0.01% | 594 |
|
|
2024
Q4 | $18.7K | Hold |
36
| – | – | ﹤0.01% | 581 |
|
|
2024
Q3 | $22.3K | Hold |
36
| – | – | ﹤0.01% | 555 |
|
|
2024
Q2 | $19.9K | Buy |
36
+18
| +100% | +$10.3K | ﹤0.01% | 549 |
|
|
2024
Q1 | $10.5K | Hold |
18
| – | – | ﹤0.01% | 616 |
|
|
2023
Q4 | $9.55K | Sell |
18
-1
| -5% | -$484 | ﹤0.01% | 597 |
|
|
2023
Q3 | $9.62K | Sell |
19
-2
| -10% | -$1.07K | ﹤0.01% | 587 |
|
|
2023
Q2 | $11K | Hold |
21
| – | – | ﹤0.01% | 571 |
|
|
2023
Q1 | $12.1K | Sell |
21
-20
| -49% | -$11.3K | ﹤0.01% | 553 |
|
|
2022
Q4 | $22 | Hold |
41
| – | – | ﹤0.01% | 524 |
|
|
2022
Q3 | $20 | Sell |
41
-2
| -5% | -$1.12K | ﹤0.01% | 514 |
|
|
2022
Q2 | $23 | Hold |
43
| – | – | ﹤0.01% | 497 |
|
|
2022
Q1 | $25 | Hold |
43
| – | – | ﹤0.01% | 492 |
|
|
2021
Q4 | $28 | Sell |
43
-3
| -7% | -$1.87K | ﹤0.01% | 459 |
|
|
2021
Q3 | $26 | Hold |
46
| – | – | ﹤0.01% | 460 |
|
|
2021
Q2 | $23 | Sell |
46
-5
| -10% | -$2.36K | ﹤0.01% | 464 |
|
|
2021
Q1 | $23 | Hold |
51
| – | – | ﹤0.01% | 451 |
|
|
2020
Q4 | $23 | Buy |
51
+20
| +65% | +$9.38K | ﹤0.01% | 414 |
|
|
2020
Q3 | $13 | Hold |
31
| – | – | ﹤0.01% | 476 |
|
|
2020
Q2 | $11 | Hold |
31
| – | – | ﹤0.01% | 475 |
|
|
2020
Q1 | $8 | Buy |
+31
| New | +$9.78K | ﹤0.01% | 498 |
|
|
2019
Q2 | $12 | Buy |
+44
| New | +$12.1K | ﹤0.01% | 452 |
|
|
2018
Q4 | $7.38K | Sell |
33
-21
| -39% | -$4.93K | ﹤0.01% | 520 |
|
|
2018
Q3 | $13.4K | Buy |
54
+4
| +8% | +$920 | ﹤0.01% | 436 |
|
|
2018
Q2 | $10.3K | Sell |
50
-7
| -12% | -$1.49K | ﹤0.01% | 557 |
|
|
2018
Q1 | $11.6K | Buy |
57
+3
| +6% | +$630 | 0.01% | 517 |
|
|
2017
Q4 | $10.9K | Sell |
54
-33
| -38% | -$6.32K | 0.01% | 546 |
|
|
2017
Q3 | $16.8K | Hold |
87
| – | – | 0.01% | 426 |
|
|
2017
Q2 | $15.5K | Buy |
87
+30
| +53% | +$5.04K | 0.01% | 430 |
|
|
2017
Q1 | $8.71K | Hold |
57
| – | – | ﹤0.01% | 540 |
|
|
2016
Q4 | $8.34K | Buy |
+57
| New | +$8.4K | 0.01% | 439 |
|
Other funds holding TMO
Westside Investment Management's TMO Position: Q2 2026 in Review
Westside Investment Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 100 shares worth $50.1K. The position accounts for 0.01% of the portfolio, ranked #587.
Westside Investment Management first reported a position in TMO in Q4 2016 and has held it in 36 quarters since. The position peaked at $59.1K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Westside Investment Management held 100 shares of Thermo Fisher Scientific worth $50.1K as of Q2 2026.
- Westside Investment Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
- Thermo Fisher Scientific made up 0.01% of Westside Investment Management's portfolio in Q2 2026, its #587 holding.
- Westside Investment Management first reported a position in Thermo Fisher Scientific in Q4 2016 and has held it in 36 quarters since.
- Westside Investment Management's Thermo Fisher Scientific position peaked at $59.1K in Q4 2025.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.